• EAACI
  • Events
  • Professionals
  • Patients
  • News
Become a Member
Become a Member

EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

Favorable Benefit-Risk Profile of Avapritinib in Indolent Systemic Mastocytosis Is Maintained After 3 Years of Therapy: Longer-Term Analysis of the PIONEER Study

Friday 13 Jun, 12:21 PM - 12:28 PM Glasgow, United Kingdom
10:21 AM - 10:28 AM Your local time
×